What is it about?
Description of modulating factors in two common recessive LGMD shows progression of disease with time both for dysferlin deficiency and calpain deficiency and an early onset of disease in calpainopathy with complete loss of protein
Featured Image
Why is it important?
First study to investigate and compare two common LGMDs
Perspectives
Basis for clinical trials in LGMDs that are still missing a valid therapeutical approach.
Prof Corrado Angelini
Universita degli Studi di Padova Polo Bibliotecario di Scienze Farmacologia e Scienze Farmaceutiche
Read the Original
This page is a summary of: The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B), Neurological Research, February 2010, Taylor & Francis,
DOI: 10.1179/174313209x380847.
You can read the full text:
Contributors
The following have contributed to this page
